BridgeBio Pharma, Inc. Common Stock (BBIO) Sentiment
30-day SentiSense Score 0.68 · Neutral · ▲ warming · as of 2026-08-09
BBIO sentiment is neutral (30-day SentiSense Score 1) and strengthening from a month ago; today's read of 0 is in line with its 30-day average. Attention averages ~5 mentions/day (1 today).
- Sentiment (30-day)
- Neutral
- SentiSense Score (30-day avg)
- 0.68
- Today's read
- 0 (Neutral)
- Mentions / day (30-day avg)
- 5 (1 today)
Where the conversation is happening
- News
- Neutral · 63% of mentions
- X
- Neutral · 25% of mentions
- Neutral · 12% of mentions
What's driving it
- Pharmaceuticals and Medical News - July 22, 2026 (+0.38)
- BridgeBio's Share Price Surges on $1B Raise and Strong Infigratinib Momentum (+0.64)
- BridgeBio Secures $1B Preferred Equity Investment from KKR and Sixth Street (+0.43)
Live SentiSense Score, sentiment history, and per-source breakdown for BridgeBio Pharma, Inc. Common Stock on SentiSense.
See how BBIO's sector compares in the market sentiment heatmap